SPHS Market Cap History



Below is a table of the SPHS market cap history going back to 8/15/2013:

Date SPHS Market Cap
8/15/20131.08M
11/5/201372.84M
5/1/201453.78M
8/1/201443.80M
11/12/201444.13M
5/1/201511.79M
8/5/201514.65M
11/12/201551.38M
3/21/201628.63M
5/11/201623.31M
8/2/2016115.13M
11/2/201677.98M
3/13/201783.41M
5/10/201776.78M
8/1/201757.21M
11/6/201766.24M
3/8/201865.64M
5/10/201882.50M
8/10/201882.81M
11/8/201864.44M
3/4/201931.43M
5/6/201926.59M
8/1/201929.61M
11/1/201917.93M

Also see: SPHS Shares Outstanding History
and SPHS YTD Return
SPHS Historical Market Cap:
+57.03% CAGR
SPHS Historical Market Cap: +57.03% CAGR

Mouse over chart for data details
8/15/2013 ...11/1/2019
Sophiris Bio is a biopharmaceutical company focused on products for the treatment of urological diseases. Co. is developing topsalysin (PRX302) as a treatment for clinically significant localized prostate cancer and as a treatment for the lower urinary tract symptoms of benign prostatic hyperplasia, commonly referred to as an enlarged prostate. Topsalysin, a genetically modified recombinant protein, is delivered via ultrasound-guided injection directly into the prostate. This protein is selectively activated by enzymatically active prostate specific antigen, which is in the prostate, resulting in localized cell death and tissue disruption without damage to neighboring tissue and nerves. We show 24 historical shares outstanding datapoints in our SPHS shares outstanding history coverage, used to compute SPHS market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing SPHS market cap history over the course of time is important for investors interested in comparing SPHS's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of SPHS versus a peer is one thing; comparing SPHS market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like SPHS can fluctuate over the course of history. With this page we aim to empower investors researching SPHS by allowing them to research the SPHS market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree SPHS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Sophiris Bio (SPHS) is categorized under the Miscellaneous sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

SPIR Market Cap History
SPK Market Cap History
SPKB Market Cap History
SPNT Market Cap History
SPNV Market Cap History
SPOT Market Cap History
SPPP Market Cap History
SPRQ Market Cap History
SPTK Market Cap History
SPUN Market Cap History
More Miscellaneous companies »

 

SPHS Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.